IMAC Holdings, Inc. has introduced a new subsidiary, Ignite Proteomics LLC. This company is focused on aiding physicians in selecting the most effective cancer treatments based on protein-level insights. The move is aimed at addressing the increasing need for personalized therapy in breast cancer and other forms of the disease.

As a financial analyst, your role might involve the following: 1. Financial Analysis: You will be responsible for analyzing financial data and preparing reports based on your findings. This might include forecasting future financial performance, looking at business trends, advising on budgeting processes, or reviewing financial statements. 2. Investment Recommendations: Often, financial analysts are asked to recommend investment strategies based on their analysis. This might involve studying market trends, researching specific companies, or examining investment data. 3. Risk Assessment: Part of your role might involve assessing the financial risk associated with certain decisions. This could be related to specific investments, business strategies, or financial policies. 4. Strategic Planning: Some financial analysts are involved in strategic planning. This might include analyzing business strategies, evaluating financial implications, and making recommendations for improvements. 5. Financial Modeling: You might also be responsible for creating financial models. These are mathematical tools that are used to forecast a business's financial performance. 6. Reporting: As a financial analyst, you might be responsible for creating reports and presentations for management. This could involve explaining complex financial information in a way that is easy to understand. 7. Compliance: Ensuring compliance with financial regulations and standards might also be part of your role. This could involve staying up-to-date with the latest financial regulations, ensuring that financial practices are in line with these regulations, and advising on compliance issues. Remember, the specific duties of a financial analyst can vary widely depending on their specific role and the industry they work in.

IMAC Holdings has been notified by Nasdaq about its failure to file its quarterly report on time. The company is making efforts to file the report and comply with Nasdaq's listing rules. However, it is not certain whether it will be able to meet the deadline. This could potentially lead to a negative impact on the company's standing and overall financial stability.

Based on the provided information, IMAC Holdings, Inc. has entered into an amendment and waiver to the Common Stock Purchase Agreement with Keystone Capital Partners, LLC. The amendment allows Keystone to waive certain requirements for the issuance and sale of IMAC's shares, such as the prerequisite of a closing sale price of at least $0.25. It also waives certain restrictions related to rules of The Nasdaq Stock Market. Furthermore, the definition of Eligible Market was expanded to include the OTCQX Market, the OTCQB Market, and the OTC Pink Market.

The company has entered into amendments on March 25, 2025, to each of the promissory notes issued by the company to specific lenders on multiple dates in February and March 2025. The total principal amount of these notes is $349,500. These amendments aim to increase the principal amount of promissory notes issued by the company and to increase the number of additional promissory notes that can be authorized.

1) Brief Summary: The company's performance has been significantly negative over the past month, quarter, and week, with a performance decrease of over 90% and an average volume significantly lower than the relative volume. The company also showed negative sales growth and a large EPS surprise of 61.54%. There has been a considerable amount of insider transactions but inst ownership and insider ownership remain low. The company's outstanding shares and market cap are significantly low, and it has a high level of short interest. The company's financials show negative revenue and a large net income loss, with overall liabilities exceeding assets. 2) MARKET_SCORE: 8

: Given the company's current financial status and market performance, there is only an 8% likelihood of an upward move. 3) PRICE_TARGET: $0.03

: Given the company's poor performance and negative financials, a price target of $0.03, which is 50% lower than the latest close price, is more realistic for this company. 4) AI_RPT_HEADLINE: "Severe Performance Decline Marks Gloomy Outlook for Company"

As a financial analyst, I would choose -> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes. SEC filings provide a comprehensive view of a company's financial health, risks, and business changes which could significantly impact the stock's value. Having more of this data would certainly improve the quality and accuracy of my analysis.

====================================================== : 2025-03-31 12:40:56

# Analysis Completed Elapsed Time: 60.23 seconds